Complement inhibition for prevention of antibody-mediated rejection in immunologically high-risk heart allograft recipients.
Patel JK, Coutance G, Loupy A, Dilibero D, Hamilton M, Kittleson M, Kransdorf E, Azarbal B, Seguchi O, Zhang X, Chang D, Geft D, Czer L, Varnous S, Kobashigawa JA.
Patel JK, et al. Among authors: azarbal b.
Am J Transplant. 2021 Jul;21(7):2479-2488. doi: 10.1111/ajt.16420. Epub 2021 Feb 11.
Am J Transplant. 2021.
PMID: 33251691
Free article.
Clinical Trial.